CVR Medical Corp.
CRRVF · OTC
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | 0.10 | 0.03 | 0.11 |
| FCF Yield | -2.67% | -10.40% | -29.91% | -33.23% |
| EV / EBITDA | -5.82 | -54.06 | -1.11 | -1.51 |
| Quality | ||||
| ROIC | 16.62% | 4.23% | 313.79% | -3,661.15% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.05 | 1.04 | 0.41 | 0.59 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | – | – |
| Free Cash Flow Growth | 51.01% | 91.34% | 52.23% | 35.44% |
| Safety | ||||
| Net Debt / EBITDA | -0.99 | -14.14 | -0.02 | 0.01 |
| Interest Coverage | -7.97 | -1.09 | -67.66 | -54.32 |
| Efficiency | ||||
| Inventory Turnover | -61.34 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -1,877,077.40 | -1,758,346.80 | -959,598.50 | 0.00 |